Following a 70-year effort, China has been awarded a malaria-free certification from WHO – a notable feat for a country that reported 30 million cases of the disease annually in the 1940s. “Today we congratulate the...
Scientists now understand the mechanism that leads to platelet activation and clotting A new lifesaving treatment for people suffering from vaccine-related blood clots has been demonstrated by scientists at McMaster...
A typical flu virus is so small that a thousand of them could fit in the width of a human hair. For decades, scientists have known about the existence of viruses many times smaller than that, called microviruses. Traces...
In a new study assessing the potential of a single-dose, intranasal COVID-19 vaccine, a team from the University of Iowa and the University of Georgia found that the vaccine fully protects mice against lethal COVID-19...
Late last year, I asked: is it safe to have more than one type of COVID-19 vaccine? A trial has now addressed that question, as well as what effect combining different vaccine types has on immunity. Most COVID-19...
Immunosuppressed patients were found to exhibit impaired immune responses to treatment for Clostridioides difficile infection compared with patients who are not immunosuppressed, according to the results of a...
Australian researchers commence the first Phase 1 human trial of a COVID-19 gene-based DNA vaccine in Australia, delivered via a needle-free system. Led by the University of Sydney, Scientia Clinical Research (Sydney)...
Researchers at the Duke Human Vaccine Institute have created a vaccine with the potential to protect against multiple types of coronavirus. The new pan-coronavirus vaccine, which has had promising results in protecting...
A strategy for fighting dengue fever with bacteria-armed mosquitoes has passed its most rigorous test yet: a large, randomized, controlled trial. Researchers reported dramatic reductions in rates of dengue infection and...
Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent. Standard short-course anti-TB treatment still requires a...